Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C51H69N5O9 |
Molecular Weight | 896.1217 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 11 / 11 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12N3CC[C@@]14C5=C(C=C(OC)C(=C5)[C@]6(C[C@@]7([H])CN(C[C@](O)(CC)C7)CCC8=C6NC9=C8C=CC=C9)C(=O)OC)N(C)[C@@]4([H])[C@](O)([C@H](O)[C@]2(CC)C=CC3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)OCC
InChI
InChIKey=QSTPFUDHVVIGCL-MIESHYDTSA-N
InChI=1S/C51H69N5O9/c1-9-30(5)39(41(57)65-12-4)53-45(59)51(62)43-49(20-23-56-21-15-19-48(11-3,42(49)56)44(51)58)34-24-35(38(63-7)25-37(34)54(43)6)50(46(60)64-8)27-31-26-47(61,10-2)29-55(28-31)22-18-33-32-16-13-14-17-36(32)52-40(33)50/h13-17,19,24-25,30-31,39,42-44,52,58,61-62H,9-12,18,20-23,26-29H2,1-8H3,(H,53,59)/t30-,31-,39-,42-,43+,44+,47-,48+,49+,50-,51-/m0/s1
Vinleucinol (also known as vinblastine-isoleucinate or V-LEU) was developed as a vinca alkaloid derivative. This compound exhibited superior antitumor activity in malignant melanoma, small cell lung carcinoma, and breast cancer lines. Experiments on animals have shown that metabolite of vinleucinol was mainly responsible for the antitumor.
Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C932
Created by
admin on Fri Dec 15 15:53:37 GMT 2023 , Edited by admin on Fri Dec 15 15:53:37 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
6673
Created by
admin on Fri Dec 15 15:53:37 GMT 2023 , Edited by admin on Fri Dec 15 15:53:37 GMT 2023
|
PRIMARY | |||
|
CHEMBL2103976
Created by
admin on Fri Dec 15 15:53:37 GMT 2023 , Edited by admin on Fri Dec 15 15:53:37 GMT 2023
|
PRIMARY | |||
|
SUB00067MIG
Created by
admin on Fri Dec 15 15:53:37 GMT 2023 , Edited by admin on Fri Dec 15 15:53:37 GMT 2023
|
PRIMARY | |||
|
MUJ5BW9BWR
Created by
admin on Fri Dec 15 15:53:37 GMT 2023 , Edited by admin on Fri Dec 15 15:53:37 GMT 2023
|
PRIMARY | |||
|
81571-28-0
Created by
admin on Fri Dec 15 15:53:37 GMT 2023 , Edited by admin on Fri Dec 15 15:53:37 GMT 2023
|
PRIMARY | |||
|
10033679
Created by
admin on Fri Dec 15 15:53:37 GMT 2023 , Edited by admin on Fri Dec 15 15:53:37 GMT 2023
|
PRIMARY | |||
|
100000079113
Created by
admin on Fri Dec 15 15:53:37 GMT 2023 , Edited by admin on Fri Dec 15 15:53:37 GMT 2023
|
PRIMARY | |||
|
C080984
Created by
admin on Fri Dec 15 15:53:37 GMT 2023 , Edited by admin on Fri Dec 15 15:53:37 GMT 2023
|
PRIMARY | |||
|
C95239
Created by
admin on Fri Dec 15 15:53:37 GMT 2023 , Edited by admin on Fri Dec 15 15:53:37 GMT 2023
|
PRIMARY |
ACTIVE MOIETY